Yıldız F, Öksüzoğlu B. Efficacy and toxicity of everolimus plus exemestane in third and later lines treatment of hormone receptor-positive, HER2-negative metastatic breast cancer. J Surg Med [Internet]. 2020 Jun. 1 [cited 2024 Nov. 24];4(6):443-6. Available from: https://jsurgmed.com/article/view/745731